MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ADIL — Adial Pharmaceuticals, Inc
NasdaqAdial Pharmaceuticals, Inc
$4.13
+0.12(+2.99%)
- O
- 4.12
- H
- 4.45
- L
- 3.86
- V
- 13.39K
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About ADIL
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 27, 2018
Employees6
Stock ExchangeNasdaq
Ticker SymbolADIL
Websitehttps://www.adial.com
Key Financial Statistics
| Market Cap | $12.38M |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.31 - $5,900.00 |
| 52-Week Avg Volume | 44.9K |
| VWAP | $4.18 |
| Transactions | 369 |
| Total Recorded Bars | 2,056 days |